Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...

SkyQuest Technology Consulting published a report, titled, E-Bike Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 41.68 Billion in 2024. With a projected CAGR of ...

VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) today reported operational and financial results for ...

Keyera Corp. (TSX: KEY) ("Keyera") announced its second quarter financial results today, the highlights of which are included in this news release. To view Management's Discussion and Analysis (the ...

INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025Phase 1/2 data announced by Staidson ...

Restaurant Brands International Inc. ( NYSE: QSR) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET J. Patrick Doyle - Executive Chairman Joshua Kobza - Chief Executive Officer Kendall Ardyce ...

SBM Offshore has scheduled a conference call together with a webcast, which will be followed by a Q&A session, to discuss the Half Year 2025 Earnings release. The event is scheduled for Thursday ...

Supercars has cut the calendar in three this year with Sprint Cup and Endurance Cup winners to be crowned before ...

A collaborative study by the University of Copenhagen and Stanford University has revealed that pharmaceuticals possess unique isotopic signature ...

TU Delft participated in the Amsterdam Canal Parade for the first time, sending 80 members of its community aboard the “Engineering TU Love” ...

A system of sensors now on the East Huntington Bridge will ensure real-time monitoring to guide maintenance and extend bridge ...